Compare BioNTech SE - ADR (BNTX) vs CSX Corporation (CSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs CSX Corporation — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while CSX Corporation trades at $50.03 (market cap $92.55B). The key difference: CSX Corporation is far larger — about 4× BioNTech SE - ADR's market cap, and CSX Corporation pays a 1.12% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | CSX | |
|---|---|---|
Market Cap | $23.31B | $92.55B |
Sector | Health | Industrials |
52-Week High | $119.34 | $53.21 |
52-Week Low | $83.89 | $32.05 |
Enterprise Value | $6.60B | $110.52B |
Dividend Yield | — | 1.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About CSX Corporation
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →
